Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 CYP2B6 genotype does not alter nicotine metabolism, plasma levels, or abstinence with nicotine replacement therapy.

× No keyword cloud information.

18 in total

1. Genetic variation in nicotine metabolism predicts the efficacy of extended-duration transdermal nicotine therapy.

Authors: C Lerman; C Jepson; E P Wileyto; F Patterson; R Schnoll; M Mroziewicz; N Benowitz; R F Tyndale
Journal: Clin Pharmacol Ther Date: 2010-03-24 Impact factor: 6.875

Review 2. A review of pharmacogenetic studies of substance-related disorders.

Authors: Jermaine D Jones; Sandra D Comer
Journal: Drug Alcohol Depend Date: 2015-03-18 Impact factor: 4.492

3. Characterization of CYP2B6 in a CYP2B6-humanized mouse model: inducibility in the liver by phenobarbital and dexamethasone and role in nicotine metabolism in vivo.

Authors: Zhihua Liu; Lei Li; Hong Wu; Jing Hu; Jun Ma; Qing-Yu Zhang; Xinxin Ding
Journal: Drug Metab Dispos Date: 2014-11-19 Impact factor: 3.922

4. The Role of Genetics in Nicotine Dependence: Mapping the Pathways from Genome to Syndrome.

Authors: James Mackillop; Ezemenari Obasi; Michael T Amlung; John E McGeary; Valerie S Knopik
Journal: Curr Cardiovasc Risk Rep Date: 2010-11

Review 5. Cytochrome P450 enzymes in the brain: emerging evidence of biological significance.

Authors: Charmaine S Ferguson; Rachel F Tyndale
Journal: Trends Pharmacol Sci Date: 2011-10-03 Impact factor: 14.819

6. Nicotine oxidation by genetic variants of CYP2B6 and in human brain microsomes.

Authors: Adam Joseph Bloom; Pan-Fen Wang; Evan D Kharasch
Journal: Pharmacol Res Perspect Date: 2019-03-11

7. Variation in CYP2A6 and tobacco dependence throughout adolescence and in young adult smokers.

Authors: Meghan J Chenoweth; Marie-Pierre Sylvestre; Gisele Contreras; Maria Novalen; Jennifer O'Loughlin; Rachel F Tyndale
Journal: Drug Alcohol Depend Date: 2015-11-21 Impact factor: 4.492

8. CYP2A6 and CYP2B6 genetic variation and its association with nicotine metabolism in South Western Alaska Native people.

Authors: Matthew J Binnington; Andy Z X Zhu; Caroline C Renner; Anne P Lanier; Dorothy K Hatsukami; Neal L Benowitz; Rachel F Tyndale
Journal: Pharmacogenet Genomics Date: 2012-06 Impact factor: 2.089

Review 9. Clinical strategies to enhance the efficacy of nicotine replacement therapy for smoking cessation: a review of the literature.

Authors: Matthew J Carpenter; Bianca F Jardin; Jessica L Burris; Amanda R Mathew; Robert A Schnoll; Nancy A Rigotti; K Michael Cummings
Journal: Drugs Date: 2013-04 Impact factor: 9.546

Review 10. Nicotine dependence pharmacogenetics: role of genetic variation in nicotine-metabolizing enzymes.

Authors: Riju Ray; Rachel F Tyndale; Caryn Lerman
Journal: J Neurogenet Date: 2009-01-23 Impact factor: 1.250